Accrued Expenses and Other Current Liabilities

6 Months Ended

Jun. 30, 2020

Payables and Accruals [Abstract]

Accrued Expenses and Other Current Liabilities

Accrued Expenses and Other Current Liabilities

Accrued expenses consisted of the following:

	As of June 30, 2020		As of December 31, 2019
Accrued development milestones	$	26,881	$	12,000
Accrued employee compensation and benefits	32,195		3,521
Accrued clinical trial costs	13,238		16,476
Accrued commercialization and other professional fees	13,713		15,408
Other accrued expenses and current liabilities	32,096		4,697
	$	118,123	$	52,102